how is tirzepatide different than semaglutide Curious about the differences between today's most popular GLP-1 medications? Here's your quick guide to semaglutide, tirzepatide, and retatrutide — three powerful tools on the journey toward weight loss, metabolic balance, and Maintenance therapy on semaglutide or

Just a few years later, in 2021, the FDA approved semaglutide at a 2.4 mg dose specifically for chronic weight management in adults with obesity or overweight conditions

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ozempic specifically for glycaemic control in adults with type 2 diabetes, often in combination with other glucose-lowering medications or as monotherapy when metformin is not tolerated

This represents hard endpoint data showing actual reductions in heart attacks, strokes, and cardiovascular deaths

Ozempic Sulfur Burps, Gas, and Bloating: Why GLP-1 Medications Cause the Food-Stuck Feeling Joshua Silva, MD Jan 26 8 min read Updated: Feb 4 Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD Many people taking GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) experience digestive symptoms including bloating, sulfur-smelling burps, excess gas, early satiety, or a heavy sensation that food feels stuck after meals

The list doesn't stop there